Company profile

HemostOD SA

HemostOD's ambition is to develop donor-free, stem cell-derived, ex vivo platelets as a standardized alternative to blood donor platelet transfusions, which are facing recurrent shortage issues, threat of contamination and life-threatening complications of alloimmunization.

HemostOD SA

Source: startup.ch

More news about HemostOD SA

20.05.2022 09:17

Enerdrape ravit le Trophée PERL 2022
  • Award
    Please login or
    register to use the
    awards follow feature
    03.05.2022 16:06

    HemostOD blood platelets Manufacturing gets FIT support
  • Financing
    Please login or
    register to use the
    awards follow feature
    07.09.2021 08:46

    Oversubscribed seed round for Ecublens biotech startup
  • Financing
    Please login or
    register to use the
    awards follow feature
    11.03.2021 09:11

    17 deep-dech start-ups shortlisted for the W.A. de Vigier Award

  • Award
    Please login or
    register to use the
    awards follow feature
    HemostOD SA

    Founded
    2020

    Kanton
    VD

    Homepage

    rss